Related Experiment Video
Updated: Aug 2, 2025

12:05
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
11.7K
Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM-associated syndromes.
Michell M Lozano Chinga1,2, Alison A Bertuch3, Zeinab Afify1
1Primary Children's Hospital, University of Utah, Salt Lake City, Utah, USA.
American Journal of Medical Genetics. Part A
|April 17, 2023
Summary
The MECOM gene is crucial for blood stem cell maintenance. New variants expand understanding of MECOM-associated syndromes, highlighting the need for better variant databases and genetic counseling.
Area of Science:
- Genetics and Molecular Biology
- Hematology
- Developmental Biology
Background:
- The MECOM gene encodes critical protein isoforms for hematopoietic stem cell (HSC) self-renewal and maintenance.
- Germline MECOM variants are linked to congenital thrombocytopenia, radioulnar synostosis, and bone marrow failure.
- The phenotypic spectrum of MECOM-associated syndromes is expanding with the identification of novel pathogenic variants.
Purpose of the Study:
- To describe eight unrelated patients with novel MECOM variants, expanding the known phenotypes and genetic defects of MECOM-associated syndromes.
- To investigate potential genotype-to-phenotype correlations and the role of genetic modifiers in MECOM-associated disorders.
- To emphasize the importance of recognizing expanded clinical features for timely diagnosis and improved patient management.
Main Methods:
- Clinical characterization of eight unrelated patients presenting with diverse hematologic and non-hematologic features.
- Identification and analysis of unique MECOM variants in each patient.
- Review of existing literature on MECOM-associated syndromes and variants.
Main Results:
- Eight new cases contribute to the expanding spectrum of MECOM-associated syndromes, presenting unique MECOM variants.
- The series did not reveal a clear genotype-to-phenotype correlation, suggesting the influence of additional genetic modifiers.
- The study identified both previously known and novel hematologic and non-hematologic clinical manifestations associated with MECOM variants.
Conclusions:
- Recognition of the broadened clinical features of MECOM-associated syndromes is vital for rapid molecular diagnosis and early intervention.
- The lack of clear genotype-phenotype correlation suggests a complex interplay of genetic factors influencing disease presentation.
- Establishing a centralized, publicly accessible database for annotated MECOM variants is crucial for advancing clinical interpretation and functional studies.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
48
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
48
Bone Marrow Sampling and Transplants
370
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
370
Cardiomyopathy III: Hypertrophic Cardiomyopathy
18
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18

